Published in J Biol Chem on March 15, 1991
Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest (1993) 1.79
Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J (1992) 1.31
Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol (2007) 1.26
The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med (2013) 1.18
Conformational stability of bovine alpha-crystallin. Evidence for a destabilizing effect of ascorbate. Biochem J (1992) 0.82
Redox homeostasis of albumin in relation to alpha-lipoic acid and dihydrolipoic acid. Oxid Med Cell Longev (2010) 0.82
Effect of metal catalyzed oxidation in recombinant viral protein assemblies. Microb Cell Fact (2014) 0.79
Oxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formation. PLoS One (2014) 0.77
Structural alterations of human serum albumin caused by glycative and oxidative stressors revealed by circular dichroism analysis. Int J Mol Sci (2013) 0.76
Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin. PLoS One (2014) 0.75
Oxidative Deamination of Serum Albumins by (-)-Epigallocatechin-3-O-Gallate: A Potential Mechanism for the Formation of Innate Antigens by Antioxidants. PLoS One (2016) 0.75
Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life (2001) 1.03
The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J (1998) 1.03
New developments in anthracycline-induced cardiotoxicity. Curr Med Chem (2009) 1.01
Lycopene and cardiovascular diseases: an update. Curr Med Chem (2011) 0.98
Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes (1997) 0.97
Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone). Chem Res Toxicol (1998) 0.95
Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers. Arch Oral Biol (1999) 0.93
Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction. Chem Res Toxicol (2000) 0.92
Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity. J Clin Invest (1995) 0.91
Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci Lett (1998) 0.89
Is homocysteine a pro-oxidant? Free Radic Res (2001) 0.88
Placental alkaline phosphatase determination by inhibition with ethylendiaminetetracetic acid. Clin Chim Acta (1985) 0.86
Inhibition of salivary enzymes by cigarette smoke and the protective role of glutathione. Hum Exp Toxicol (2002) 0.86
Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity. J Clin Invest (1996) 0.86
Characterization of alkaline phosphatase inactivation by ascorbic acid. Biochim Biophys Acta (1984) 0.86
Metabolic implications of coenzyme Q10 in red blood cells and plasma lipoproteins. Mol Aspects Med (1994) 0.85
Nutritional counselling and oral nutritional supplements in head and neck cancer patients undergoing chemoradiotherapy. J Hum Nutr Diet (2012) 0.84
Self-similarity properties of alpha-crystallin supramolecular aggregates. Biophys J (1995) 0.83
Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Chem Res Toxicol (2003) 0.83
Conformational stability of bovine alpha-crystallin. Evidence for a destabilizing effect of ascorbate. Biochem J (1992) 0.82
Prooxidant action of desferrioxamine: enhancement of alkaline phosphatase inactivation by interaction with ascorbate system. Arch Biochem Biophys (1990) 0.82
Alterations of energy metabolism and glutathione levels of HL-60 cells induced by methacrylates present in composite resins. J Dent (2006) 0.81
Relation between conversion degree and cytotoxicity of a flowable bulk-fill and three conventional flowable resin-composites. Eur Rev Med Pharmacol Sci (2015) 0.79
Oxygen transport by fetal bovine hemoglobin. J Mol Biol (1996) 0.79
The relationship between the optical properties and the kinetic behaviour of ascorbate-inhibited alkaline phosphatase. Biochem J (1986) 0.78
The secondary alcohol and aglycone metabolites of doxorubicin alter metabolism of human erythrocytes. Braz J Med Biol Res (2003) 0.78
The kinetics of concurrent instantaneous and time dependent inhibition of alkaline phosphatase by urea and related compounds. Ital J Biochem (1986) 0.78
Modifications induced by ascorbic acid on alkaline phosphatase fluorescence. Ital J Biochem (1985) 0.78
NA+/K+ ATPase impairment and experimental glycation: the role of glucose autoxidation. Free Radic Res (1996) 0.78
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. J Cell Mol Med (2005) 0.78
Early conformational changes and activity modulation induced by guanidinium chloride on intestinal alkaline phosphatase. Biochem J (1987) 0.78
Biochemical properties of alkaline phosphatase from endometrial cancer cells. Enzyme (1985) 0.78
Ascorbic acid and alkaline phosphatase activity. Enzyme (1983) 0.78
Ascorbic acid stability in aqueous solutions. Acta Vitaminol Enzymol (1985) 0.78
Interaction between alkaline phosphatase and ascorbic acid by fluorescence and absorption studies. Ital J Biochem (1984) 0.78
Vitamin C-bovine serum albumin binding behaviour. Ital J Biochem (1987) 0.78
Enzyme inactivation by metal-catalyzed oxidation of coenzyme Q1. Biochim Biophys Acta (1992) 0.77
Studies on the selective chemical inhibition by urea of alkaline phosphatase isoenzymes in the reaction course. Enzyme (1984) 0.77
Antioxidant effect of coenzyme Q on hydrogen peroxide-activated myoglobin. Clin Investig (1993) 0.77
High total antioxidant activity and uric acid in tracheobronchial aspirate fluid of preterm infants during oxidative stress: an adaptive response to hyperoxia? Acta Paediatr (2000) 0.77
The interaction of short chain coenzyme Q analogs with different redox states of myoglobin. J Biol Chem (1994) 0.76
Alkaline phosphatase inactivation by mixed function oxidation systems. Arch Biochem Biophys (1987) 0.76
Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid beta-protein fragment (31-35) on isolated brain mitochondria. Neuroscience (2004) 0.76
Mixed function oxidation and enzymes: kinetic and structural properties of an oxidatively modified alkaline phosphatase. Arch Biochem Biophys (1988) 0.76
Effect of homocysteine on polymorphonuclear leukocyte activity and luminol-dependent chemiluminescence. Luminescence (2000) 0.76
Morpho-functional modifications of human neutrophils induced by aqueous cigarette smoke extract: comparison with chemiluminescence activity. Luminescence (2010) 0.76
Oxidative stress in ischemia-reperfusion injury: assessment by three independent biochemical markers. Ital Heart J (2000) 0.75
Sample and data random management in a medical laboratory equipped with automatic analysers. J Automat Chem (1982) 0.75
A kinetic approach to the evaluation of alkaline phosphatase inactivation by urea. Ital J Biochem (1984) 0.75
Modulation of alkaline phosphatase in different organs by ascorbic acid and related compounds. Acta Vitaminol Enzymol (1983) 0.75
Modification of arginine residues in calf intestinal alkaline phosphatase. Ital J Biochem (1986) 0.75
Evaluation of plasma protein antisera affinity by means of turbidimetric assays. Ric Clin Lab (1981) 0.75
Real time control procedures for monitoring SMAC analytical performance. Comput Biol Med (1983) 0.75
[Colorimetric determination of plasma vitamin C: comparison between 2,4-dinitrophenylhydrazine and phosphotungstic acid methods (author's transl)]. Acta Vitaminol Enzymol (1981) 0.75
In vitro effect of ascorbic acid on bovine kidney alkaline phosphatase activity. Acta Vitaminol Enzymol (1983) 0.75
Free radical production by activated haem proteins: protective effect of coenzyme Q. Mol Aspects Med (1994) 0.75
Electron transport system in human leukocyte mitochondria. Ital J Biochem (1974) 0.75
[Thin-layer chromatography separation of L-ascorbic acid from its oxidation products (author's transl)]. Acta Vitaminol Enzymol (1981) 0.75
Subcellular distribution of some specific enzymatic activities in human leucocytes. Enzyme (1980) 0.75
Comparison of kinetic and optical changes during guanidine denaturation of intestinal alkaline phosphatase. Ital J Biochem (1988) 0.75
Time-resolved fractionation of bone and liver alkaline phosphatase activities with a 'peeling-off' method. Enzyme (1989) 0.75
[Behavior of gamma-glutamyltranspeptidase in acute viral hepatitis]. Quad Sclavo Diagn (1983) 0.75
Vitamin C in normal human mononuclear and polymorphonuclear leukocytes. Acta Vitaminol Enzymol (1982) 0.75
(Na+-K+)-ATPase interaction with L-ascorbic acid. Effect on p-nitrohenylphosphatase partial reaction. Ital J Biochem (1989) 0.75